Cutting-Edge Peptide Science Powered by BPC-157, KPV, and Thymosin Beta 4, studied for their therapeutic potential
Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases
ERK1/2 & VEGFR2 Mechanism Musculoskeletal Scoping Review (PMC, 2025) A 2025 scoping review confirmed BPC-157 activates VEGFR2 and drives nitric oxide synthesis via the Akt-eNOS axis, promoting angiogenesis, fibroblast activity, and neuromuscular stabilisation
In rare cases, allergic reactions like difficulty breathing, swelling of the face or throat, or a fast heartbeat may occur
This same commitment to quality extends across our full collection of peptides, ensuring that every project, from neurological to metabolic research, is built on a bedrock of purity
LJP-394 (Abetimus Sodium) LJP-394 (Abetimus sodium) is a synthetic peptide developed to induce immune tolerance to double-stranded DNA (dsDNA), a key autoantigen in SLE